TY - JOUR
T1 - Is oxidative stress associated with disease severity, pulmonary function and metabolic syndrome in chronic obstructive pulmonary disease?
AU - Sepúlveda Loyola, W. A.
AU - Vilaça Cavallari Machado, F.
AU - Araújo de Castro, L.
AU - Hissnauer Leal Baltus, T.
AU - Rampazzo Morelli, N.
AU - Landucci Bonifácio, K.
AU - Morita, A. A.
AU - Michelin, A. P.
AU - Sabbatini Barbosa, D.
AU - Probst, V. S.
N1 - Publisher Copyright:
© 2019 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)
PY - 2019/12
Y1 - 2019/12
N2 - Objective: To investigate associations between oxidant/antioxidant biomarkers with the disease severity, pulmonary function and diagnosis of metabolic syndrome (MetS) in patients with COPD. Methods: Seventy-four subjects were included, 39 with COPD (age 69 ± 7 years; female 41%) and 35 for control group (age 69 ± 7 years; female 43%). They were diagnosed with MetS and allocated in one of 4 subgroups: COPD and control, with and without MetS, respectively. Advanced oxidation protein products (AOPP), paraoxonase-1, catalase activity, sulfhydryl group and total lipid hydroperoxide were assayed. Pulmonary function was performed with a plethysmograph. Results: COPD severity (GOLD ≥ 3) and pulmonary function were associated with sulfhydryl group and AOPP (P ≤.03 for all). The prevalence of MetS was associated with AOPP in COPD (P =.04). Individuals with COPD and MetS showed higher AOPP compared to COPD without MetS (P <.0001). Conclusion: COPD severity, worse pulmonary function and presence of metabolic syndrome are associated with oxidative stress in individuals with COPD.
AB - Objective: To investigate associations between oxidant/antioxidant biomarkers with the disease severity, pulmonary function and diagnosis of metabolic syndrome (MetS) in patients with COPD. Methods: Seventy-four subjects were included, 39 with COPD (age 69 ± 7 years; female 41%) and 35 for control group (age 69 ± 7 years; female 43%). They were diagnosed with MetS and allocated in one of 4 subgroups: COPD and control, with and without MetS, respectively. Advanced oxidation protein products (AOPP), paraoxonase-1, catalase activity, sulfhydryl group and total lipid hydroperoxide were assayed. Pulmonary function was performed with a plethysmograph. Results: COPD severity (GOLD ≥ 3) and pulmonary function were associated with sulfhydryl group and AOPP (P ≤.03 for all). The prevalence of MetS was associated with AOPP in COPD (P =.04). Individuals with COPD and MetS showed higher AOPP compared to COPD without MetS (P <.0001). Conclusion: COPD severity, worse pulmonary function and presence of metabolic syndrome are associated with oxidative stress in individuals with COPD.
KW - Chronic obstructive pulmonary disease
KW - Metabolic syndrome
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85068058809&partnerID=8YFLogxK
U2 - 10.1016/j.rce.2019.04.007
DO - 10.1016/j.rce.2019.04.007
M3 - Article
AN - SCOPUS:85068058809
SN - 0014-2565
VL - 219
SP - 477
EP - 484
JO - Revista Clinica Espanola
JF - Revista Clinica Espanola
IS - 9
ER -